| Name | Title | Contact Details |
|---|
3jam enables people to send and receive text messages using their phone number from the web, social networks, and PC desktop.
PetScreening gives Property Managers and Landlords the ability to screen renters pets and validate the status of assistance animals.
Everdays is a space for consumers and end-of-life professionals to create a social community around a passing – to privately message condolences, share photo and video memories, participate in events, stay connected to important life events, and be there for loved ones when it matters most.
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Intergraph Corporation is one of the leading providers in Software and Internet. It is based in Huntsville, AL. To find more information about Intergraph Corporation, please visit www.intergraph.com.